Anavex Life Sciences Corp. (AVXL)
4.085
-0.32
(-7.37%)
USD |
NASDAQ |
Dec 10, 16:00
4.15
+0.06
(+1.59%)
After-Hours: 20:00
Anavex Life Sciences Market Cap: 364.99M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vanda Pharmaceuticals, Inc. | 397.72M |
| ADMA Biologics, Inc. | 4.755B |
| Aldeyra Therapeutics, Inc. | 287.28M |
| ACADIA Pharmaceuticals, Inc. | 4.535B |
| CorMedix, Inc. | 904.89M |
Market Cap Related Metrics
| PEG Ratio | -1.310 |
| Price to Book Value | 3.847 |
| Price | 4.085 |
| Earnings Yield | -13.31% |
| PEGY Ratio | -1.310 |